McCollum Christoferson Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Hold
1,710
0.6% 41
2026
Q1
$1.57M Hold
1,710
0.47% 44
2025
Q4
$1.84M Hold
1,710
0.53% 36
2025
Q3
$1.3M Buy
1,710
+1,250
+272% +$930K 0.37% 40
2025
Q2
$359K Sell
460
-56
-11% -$43.5K 0.11% 55
2025
Q1
$426K Hold
516
0.13% 51
2024
Q4
$398K Hold
516
0.12% 51
2024
Q3
$457K Hold
516
0.13% 50
2024
Q2
$467K Buy
516
+20
+4% +$16K 0.14% 49
2024
Q1
$386K Buy
496
+46
+10% +$32.7K 0.11% 49
2023
Q4
$262K Hold
450
0.08% 58
2023
Q3
$242K Hold
450
0.07% 61
2023
Q2
$211K Buy
+450
New +$189K 0.06% 68
2020
Q4
Sell
-1,750
Closed -$259K 73
2020
Q3
$259K Buy
+1,750
New +$271K 0.07% 66

Other funds holding LLY

McCollum Christoferson Group's LLY Position: Q2 2026 in Review

McCollum Christoferson Group held its Eli Lilly (LLY) position steady in Q2 2026 at 1,710 shares worth $2.05M. The position accounts for 0.6% of the portfolio, ranked #41.

McCollum Christoferson Group first reported a position in LLY in Q3 2020 and has held it in 14 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • McCollum Christoferson Group held 1,710 shares of Eli Lilly worth $2.05M as of Q2 2026.
  • McCollum Christoferson Group left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.6% of McCollum Christoferson Group's portfolio in Q2 2026, its #41 holding.
  • McCollum Christoferson Group first reported a position in Eli Lilly in Q3 2020 and has held it in 14 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on McCollum Christoferson Group's 13F filing for Q2 2026, filed 13 Jul 2026.